Cargando…
The potential of CAR T therapy for relapsed or refractory pediatric and young adult B-cell ALL
Recent advancements in immunooncology have resulted in the generation of novel therapies such as chimeric antigen receptor (CAR) T cells, which have revolutionized the treatment of pediatric patients with relapsed or refractory B-cell acute lymphoblastic leukemia. The journey of tisagenlecleucel (fo...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6130274/ https://www.ncbi.nlm.nih.gov/pubmed/30233192 http://dx.doi.org/10.2147/TCRM.S146309 |